These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24632612)

  • 41. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
    Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S
    Oncogene; 2001 Oct; 20(45):6538-43. PubMed ID: 11641778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiogenic acceleration of Neu induced mammary tumor progression and metastasis.
    Oshima RG; Lesperance J; Munoz V; Hebbard L; Ranscht B; Sharan N; Muller WJ; Hauser CA; Cardiff RD
    Cancer Res; 2004 Jan; 64(1):169-79. PubMed ID: 14729621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
    Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ
    Cancer Res; 2004 May; 64(9):3171-8. PubMed ID: 15126356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis.
    Barrington RE; Subler MA; Rands E; Omer CA; Miller PJ; Hundley JE; Koester SK; Troyer DA; Bearss DJ; Conner MW; Gibbs JB; Hamilton K; Koblan KS; Mosser SD; O'Neill TJ; Schaber MD; Senderak ET; Windle JJ; Oliff A; Kohl NE
    Mol Cell Biol; 1998 Jan; 18(1):85-92. PubMed ID: 9418856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.
    Wong AW; Dunlap SM; Holcomb VB; Nunez NP
    Alcohol Clin Exp Res; 2012 Apr; 36(4):577-87. PubMed ID: 21981381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice.
    Ma Z; Parris AB; Xiao Z; Howard EW; Kosanke SD; Feng X; Yang X
    J Exp Clin Cancer Res; 2017 Jan; 36(1):6. PubMed ID: 28061785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
    Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
    Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
    Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
    Hewitt SC; Bocchinfuso WP; Zhai J; Harrell C; Koonce L; Clark J; Myers P; Korach KS
    Cancer Res; 2002 May; 62(10):2798-805. PubMed ID: 12019156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.
    Quan L; Dittmar A; Zhou Y; Hutson A; Stassen AP; Demant P
    Genes Chromosomes Cancer; 2012 Jul; 51(7):631-43. PubMed ID: 22419448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.
    Hulit J; Suyama K; Chung S; Keren R; Agiostratidou G; Shan W; Dong X; Williams TM; Lisanti MP; Knudsen K; Hazan RB
    Cancer Res; 2007 Apr; 67(7):3106-16. PubMed ID: 17409417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.
    Heckman-Stoddard BM; Vargo-Gogola T; McHenry PR; Jiang V; Herrick MP; Hilsenbeck SG; Settleman J; Rosen JM
    Breast Cancer Res; 2009; 11(4):R61. PubMed ID: 19703301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting FACT complex suppresses mammary tumorigenesis in Her2/neu transgenic mice.
    Koman IE; Commane M; Paszkiewicz G; Hoonjan B; Pal S; Safina A; Toshkov I; Purmal AA; Wang D; Liu S; Morrison C; Gudkov AV; Gurova KV
    Cancer Prev Res (Phila); 2012 Aug; 5(8):1025-35. PubMed ID: 22689915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice.
    Henry MD; Triplett AA; Oh KB; Smith GH; Wagner KU
    Oncogene; 2004 Sep; 23(41):6980-5. PubMed ID: 15286714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells.
    Kumar R; Balasenthil S; Pakala SB; Rayala SK; Sahin AA; Ohshiro K
    Cancer Res; 2010 Aug; 70(16):6598-608. PubMed ID: 20710043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis.
    Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R
    Int J Cancer; 2000 Feb; 85(4):578-83. PubMed ID: 10699933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo imaging reveals PKA regulation of ERK activity during neutrophil recruitment to inflamed intestines.
    Mizuno R; Kamioka Y; Kabashima K; Imajo M; Sumiyama K; Nakasho E; Ito T; Hamazaki Y; Okuchi Y; Sakai Y; Kiyokawa E; Matsuda M
    J Exp Med; 2014 Jun; 211(6):1123-36. PubMed ID: 24842369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic mice.
    Zhao Q; Parris AB; Howard EW; Zhao M; Ma Z; Guo Z; Xing Y; Yang X
    Sci Rep; 2017 Sep; 7(1):11306. PubMed ID: 28900173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.
    Muller WJ; Arteaga CL; Muthuswamy SK; Siegel PM; Webster MA; Cardiff RD; Meise KS; Li F; Halter SA; Coffey RJ
    Mol Cell Biol; 1996 Oct; 16(10):5726-36. PubMed ID: 8816486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.